Farmacéutica

Volker Bühler

Generic Drug Formulations

Fine Chemicals
(4th edition 2001)

1 Introduction
1.1 Preface
A selection of more than 500 formulations of human and veterinary drugs
are presented in this booklet. They
have all been developed in the last 22
years in the Applications Laboratories
of BASF AG and are in solid, liquid,
and semi-solid form. However, emphasis is placed ontablets. Human
and veterinary medicines have not
been dealt with in separate chapters,
because the technologies and excipients are the same.

BASF Pharma Ingredients G eneric Drug Formulations 2001

1.2 List of all formulations aranged alphabetically

A
Aceclofenac Gel-Cream (1.5 %)
Aceclofenac Instant Granules (50 mg)
Acetylcysteine Effervescent Tablets
(600 mg)
Acetylsalicylic Acid +Paracetamol
(= Acetaminophen) + Caffeine
Tablets (250 mg + 250 mg + 50 mg)
Acetylsalicylic Acid + Paracetamol
(= Acetaminophen) + Caffeine Tablets (400 mg + 100 mg + 30 mg)
Acetylsalicylic Acid + Paracetamol
(= Acetaminophen) Tablets (250 mg
+ 250 mg)
Acetylsalicylic Acid + Vitamin C Effervescent Tablets (400 mg + 250 mg)
Acetylsalicylic Acid + Vitamin C Tablets
(325 mg + 250 mg)Acetylsalicylic Acid + Vitamin C Tablets
(400 mg + 250 mg)
Acetylsalicylic Acid Tablets (400 mg)
Acetylsalicylic Acid Tablets (500 mg)
Aciclovir Oral Suspension
(2 % = 200 mg/10 ml)
Adhesive Buccal Tablets
(Basic Formulation)
Albendazole Dry Syrup or Instant
Granules (200 mg)
Albendazole Tablets, (100 mg)
Alginic Acid + Aluminium Hydroxide +
Magnesium Silicate Tablets
(500 mg + 100 mg + 25mg)
Aloe Vera Gel
Alpha-Bisabolol Aqueous Mouth Wash
Solution (0.2 %)
Alpha-Bisabolol Buccal or Topical
Solution (0.1%)
Alpha-Bisabolol Mouth Wash Solution
(0.5 %)
Alpha-Methyldopa Tablet Cores
(250 mg), DC
Alpha-Methyldopa Tablet Cores
(250 mg), WG

Alpha-Methyldopa Tablets
(500 mg), DC
Alpha-Methyldopa Tablets
(500 mg), WG
Alprazolam Tablets (0.5 mg)
Aluminium AcetylsalicylateTablets
(250 mg)
Aluminium Hydroxide + Magnesium
Carbonate Dry Syrup
(12.5 % + 12.5 %)
Aluminium Hydroxide + Magnesium
carbonate/oxide + Simethicone
Tablets (150 mg + 250 mg + 90 mg)
Aluminium Hydroxide + Magnesium
Hydroxide + Simethicone Suspension (8 % + 8 % + 0.8 %)
Aluminium Hydroxide + Magnesium
Hydroxide Chewable Tablets
(200 mg + 200 mg)
Aluminium Hydroxide + MagnesiumHydroxide Suspension (4 % + 4 %)
Aluminium Hydroxide + Magnesium
Silicate Chewable Tablets
(120 mg + 250 mg)
Ambroxol Tablets (30 mg)
Aminophylline Tablets (90 mg)
Aminophylline Tablets (100 mg), DC
Aminophylline Tablets, WG (100 mg)
Amitryptylline Tablets
(10 mg and 25 mg)
Amoxicillin Dry Syrup
(5 % = 500 mg/10 ml)
Amoxicillin Lyophylisate for Injection
(250 mg)
Amoxicillin Tablets (125 mg)Ampicillin + Cloxacillin Oily Suspension
(1.5 % + 4.0 %)
Ampicillin Dry Syrup
(5 % = 500 mg/10 ml)
Ampicillin Tablets (250 mg)
Ampicillin Tablets (500 mg)
Anise Oil Solution (1%)
Asparagus Extract + Parsley Extract
Tablets (200 mg + 200 mg)

BASF Pharma Ingredients G eneric Drug Formulations 2001

Aspartame Effervescent Tablets
(20 mg)
Aspartame Tablets (25 mg), DC
AspartameTablets (25 mg), WG
Atenolol Tablets (90 mg)
Azithromycin Dry Syrup
(5 % = 500 mg/10 ml)
Azithromycin Suspension
(5 % = 500 mg/10 ml)
Azulene solution (1%)
B
Barium Sulfate Oral Suspension (23 %)
Basic Cream for Different Active
Ingredients
Benzhexol Tablets (5 mg)
Benzoyl Peroxide + Alpha-Bisabolol
Gel (5.0 % + 0.2 %)
Benzyl Benzoate Solution (10 %)
Benzylpenicilline +Dihydrostreptomycin Injectable Suspension
(200,000 units + 200 mg/ml)
Berberine Tablets (5 mg)
Beta Carotene + Vitamin C + Vitamin E
Chewable Tablets (3 mg + 50 mg +
25 mg)
Beta Carotene + Vitamin C + Vitamin E
Chewable Tablets (10 mg + 500 mg
+ 250 mg)
Beta Carotene + Vitamin C + Vitamin E
Effervescent Tablets (12 mg +
150 mg + 25 mg)
Beta Carotene + Vitamin C + Vitamin E
Tablets (6 mg + 100 mg +...